Urine S100 proteins as potential biomarkers of lupus nephritis activity-Reference-Cited by-同舟云学术

Urine S100 proteins as potential biomarkers of lupus nephritis activity

Published:2017-10-24 Issue:1 Volume:19 Page:
ISSN:1478-6362
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Turnier Jessica L.,Fall Ndate,Thornton Sherry,Witte David,Bennett Michael R.,Appenzeller Simone,Klein-Gitelman Marisa S.,Grom Alexei A.,Brunner Hermine I.

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13075-017-1444-4.pdf

Reference36 articles.

1. Hiraki LT, Feldman CH, Liu J, Alarcón GS, Fischer MA, Winkelmayer WC, et al. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum. 2012;64:2669–76.

2. Rianthavorn P, Buddhasri A. Long-term renal outcomes of childhood-onset global and segmental diffuse proliferative lupus nephritis. Pediatr Nephrol. 2015;30:1969–76.

3. Vachvanichsanong P, McNeil E. Pediatric lupus nephritis: more options, more chances? Lupus. 2013;22:545–53.

4. Perfumo F, Martini A. Lupus nephritis in children. Lupus. 2005;14:83–8.

5. Mina R, Abulaban K, Klein-Gitelman MS, Eberhard BA, Ardoin SP, Singer N, et al. Validation of the lupus nephritis clinical indices in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2016;68:195–202.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applying 12 machine learning algorithms and Non-negative Matrix Factorization for robust prediction of lupus nephritis;Frontiers in Immunology;2024-08-19

2. Characterization of macrophages in ischemia–reperfusion injury-induced acute kidney injury based on single-cell RNA-Seq and bulk RNA-Seq analysis;International Immunopharmacology;2024-03

3. S100A4 a classical DAMP as a therapeutic target in fibrosis;Matrix Biology;2024-03

4. Deciphering the Function of New Therapeutic Targets and Prospective Biomarkers in the Management of Psoriasis;Current Drug Targets;2023-12

5. Podocyte injury and death: New insights into lupus nephritis pathogenesis and therapy;Rheumatology & Autoimmunity;2023-12